claim: a five years course of ivermectin for the treatment of covid-19 may reduce the duration of illness
evidence_1: ivermectin may be effective for the treatment of early-onset mild covid-19 in adult patients.", "ivermectin to prevent hospitalizations in patients with covid-19 (ivercor-covid19): a structured summary of a study protocol for a randomized controlled trial.", "a 5-day course of ivermectin was found to be safe and effective in treating adult patients with mild covid-19.", "a 5-day course of ivermectin resulted in an earlier clearance of the virus compared to placebo ( p = 0.005), thus indicating that early intervention with this agent may limit viral replication within the host."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )